News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
200,144 Results
Type
Article (19531)
Company Profile (41)
Press Release (180572)
Section
Business (51108)
Career Advice (258)
Deals (7340)
Drug Delivery (28)
Drug Development (38787)
Employer Resources (21)
FDA (5926)
Job Trends (4896)
News (100317)
Policy (8070)
Tag
Academia (1472)
Alliances (14561)
Alzheimer's disease (1040)
Antibody-drug conjugate (ADC) (50)
Approvals (5889)
Artificial intelligence (44)
Bankruptcy (33)
Best Places to Work (4550)
Biotechnology (38)
Breast cancer (86)
Cancer (740)
Career advice (227)
Cell therapy (107)
Clinical research (29808)
Collaboration (155)
Compensation (33)
COVID-19 (744)
C-suite (33)
Cystic fibrosis (43)
Data (485)
Diagnostics (1982)
Earnings (17144)
Events (31041)
Executive appointments (91)
FDA (6159)
Funding (136)
Gene therapy (75)
GLP-1 (161)
Government (1200)
Healthcare (7579)
Infectious disease (767)
Inflammatory bowel disease (33)
Interviews (38)
IPO (4020)
Job creations (493)
Job search strategy (197)
Layoffs (114)
Legal (945)
Liver cancer (43)
Lung cancer (139)
Manufacturing (47)
Medical device (3074)
Medtech (3076)
Mergers & acquisitions (3372)
Metabolic disorders (73)
Neuroscience (1193)
NextGen Class of 2024 (1945)
Non-profit (2988)
Northern California (505)
Obesity (46)
Opinion (54)
Ovarian cancer (34)
Parkinson's disease (54)
Patents (33)
People (15918)
Phase I (10970)
Phase II (12978)
Phase III (9341)
Pipeline (113)
Postmarket research (891)
Preclinical (4562)
Prostate cancer (30)
Radiopharmaceuticals (160)
Rare diseases (109)
Real estate (975)
Regulatory (6469)
Research institute (1362)
Resumes & cover letters (30)
Southern California (428)
Startups (1097)
United States (4418)
Vaccines (223)
Date
Today (93)
Last 7 days (327)
Last 30 days (1243)
Last 365 days (14610)
2024 (12414)
2023 (16674)
2022 (20467)
2021 (20799)
2020 (18130)
2019 (15527)
2018 (11560)
2017 (10681)
2016 (9930)
2015 (11170)
2014 (7552)
2013 (5799)
2012 (5779)
2011 (5805)
2010 (5057)
Location
Africa (160)
Asia (12662)
Australia (1866)
California (1055)
Canada (371)
China (100)
Colorado (50)
Connecticut (55)
Delaware (30)
Europe (26358)
Florida (152)
Illinois (113)
Indiana (59)
Japan (34)
Kansas (46)
Maryland (176)
Massachusetts (924)
Minnesota (76)
New Jersey (327)
New York (383)
North Carolina (206)
Northern California (505)
Ohio (45)
Pennsylvania (260)
South America (210)
Southern California (428)
Texas (191)
Washington State (128)
200,144 Results for "pediatric brain tumor foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Ursula Burns, former Xerox CEO, and Jordan Wertlieb, EVP and COO of Hearst, appointed to the Pediatric Brain Tumor Foundation’s Advisory Board as inaugural members
The Pediatric Brain Tumor Foundation announced the appointment of Ursula Burns and Jordan Wertlieb as inaugural members of the organization’s new Advisory Board.
June 25, 2024
·
5 min read
FDA
PNOC Foundation, a Leading Non-profit to Further Advancements in Pediatric Brain Cancer, Announces FDA Approval of Tovorafenib (Day101) in Partnership With PNOC Scientific Consortium and Day One Biopharmaceuticals
The Pediatric Neuro-Oncology Consortium Foundation, a platinum rated non-profit dedicated to supporting advancements in childhood brain cancer research and clinical trials, announces the FDA approval of Tovorafenib, a significant advancement in the fight against pediatric low-grade glioma brain tumors.
April 24, 2024
·
3 min read
Press Releases
TippingPoint Biosciences Closes New Funding to Support Drug for Rare Pediatric Brain Tumor
September 4, 2024
·
5 min read
FDA
Day One’s Ojemda Gets FDA Accelerated Approval for Pediatric Brain Tumor
The FDA on Tuesday approved Day One Biopharmaceuticals’ type II RAF inhibitor Ojemda, which is designed to penetrate the blood-brain barrier, for the treatment of relapsed or refractory pediatric low-grade glioma.
April 24, 2024
·
2 min read
·
Tristan Manalac
Press Releases
American Brain Tumor Association Awards Over $1 Million in New Grants to Advance Brain Cancer Research
October 23, 2024
·
4 min read
Press Releases
American Brain Tumor Association’s Metastatic Brain Tumor Collaborative Announces $50,000 Research Grant Opportunity to Fund High-Risk, High-Impact CNS Metastasis Research
October 31, 2024
·
3 min read
BioMidwest
Pediatric Brain Tumor Foundation and Marsh McLennan Agency Host 19th Annual Auction and Broadcast Benefiting The Butterfly Fund Financial Assistance Program
The 2023 Marsh McLennan Agency Charity Classic, benefiting the Pediatric Brain Tumor Foundation, will take place on Wednesday, September 27, with an auction and live broadcast, followed by the annual Cocktails & Cornhole event on October 24.
September 27, 2023
·
4 min read
BioMidwest
American Brain Tumor Association Announces $1.3 Million in New Funding to Accelerate Adult and Pediatric Brain Tumor Research
The American Brain Tumor Association announced the funding of $1.37 million towards 23 new research grants to advance brain tumor science and treatments, across all brain tumor types and ages.
November 8, 2023
·
4 min read
Pharm Country
Children’s Tumor Foundation Presents the 2024 Global NF Conference in Brussels: Shaping What’s Next for NF
The 2024 Global NF Conference, organized by the Children’s Tumor Foundation and the European NF Group, and hosted by Children’s Tumor Foundation Europe, is the foremost assembly defining the scientific and medical future of the genetic conditions neurofibromatosis and schwannomatosis.
June 17, 2024
·
4 min read
Press Releases
Nikon Small World Competition Celebrates 50 Years with Groundbreaking Image of Brain Tumor Cells
October 18, 2024
·
19 min read
1 of 20,015
Next
